Scientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.

In a study published in 2023, young and old Caenorhabditis elegans worms treated with the drug – which is normally used to ...

The results showed that patients taking diltiazem had a 20% higher risk of being hospitalized or dying due to serious ...

Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and ...

Discover 7 tips to lower high blood pressure naturally, from the DASH diet to stress management techniques that can help you ...

A recent study has found a possible link between a commonly prescribed high blood pressure drug and an increased risk of ...

Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in ...

The survey by the department of dietetics at PGIMER, Chandigarh, conducted from March 10-15, focused on 60 hypertensive patients, mostly senior citizens (60% male and 40% female), at special diet clin ...

Topline data were announced from a trial investigating lorundrostat for the treatment of uncontrolled hypertension or resistant hypertension.

Findings from a pair of studies in tough-to-treat hypertension establish Mineralys’ drug as a “derisked, almost-commercial ...

The Launch-HTN trial evaluated lorundrostat as an add-on therapy to an existing, prescribed background treatment of two-to-five anti-hypertensive medications, while the Advance-HTN trial evaluated the ...